MedCity News

FEBRUARY 22, 2024

Perelel’s $10 million pledge comes in the form of product donations and funding grants and will go to the Magee-Womens Research Institute and the Good+Foundation through 2027.

106

106

PharmaTech

OCTOBER 26, 2023

As CMOs continue to invest in cell culture capacity, some are expected to surpass top in-house companies.

52

52

Pharmaceutical Commerce

APRIL 5, 2023

Rise in value attributed to the ongoing decentralization of pharmacies.

Marketing 52

Marketing Pharma 52

PharmExec

FEBRUARY 9, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Marketing 40

Marketing 40

Pharmaceutical Technology

OCTOBER 6, 2023

Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.

Sales 59

Sales 59

Pharmacy Times

JANUARY 10, 2023

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

Medicine 52

Medicine 52

Pharmaceutical Commerce

JANUARY 25, 2023

Annual report finds continuing impact of COVID-19 on global markets

Marketing 52

Marketing Medicine 52

European Pharmaceutical Review

FEBRUARY 27, 2024

The facility has been designed to meet the highest environmental sustainability standards, to help Amgen’s reach its target of carbon neutrality in all operations by 2027, the company noted. .” Amgen Ohio is nearly 300,000 ft 2 in size and will employ 400 full-time staff.

Manufacturing 103

Manufacturing Food and Drug Administration Food Networking 103

World of DTC Marketing

JUNE 15, 2021

Billion by 2027, growing at a CAGR of 16.4% from 2020 to 2027. According to Verified Market Research, the Global Telehealth Market was valued at USD 21.17 Billion in 2019 and is projected to reach USD 71.44

Side effects 193

Side effects Insurance Doctors Pharma 193

Pharmaceutical Technology

MARCH 15, 2023

The committee has also launched new targets for December 2027. Additionally, 50 of the private companies in the UK need to have a minimum of one ethnic minority director on the main board by December 2027. Under these targets, each FTSE 350 company will be required to set a percentage target for senior management positions.

Management 52

Management Pharma 52

European Pharmaceutical Review

MARCH 14, 2024

A global Phase III clinical trial is being planned, with an expected regulatory submission in 2027. The data from the studies suggested that the vaccine has “blockbuster potential”, according to SK bioscience.

Manufacturing 89

Manufacturing Marketing Medicine Pharma 89

World of DTC Marketing

MARCH 28, 2022

If the trend continues at the current rate, millennial treatment costs are still projected to be close to $4,500 annually, roughly 33 percent higher than Generation X’s at a comparable age, by 2027. That’s about $375 per month. And what are we doing about it?

Insurance 249

Insurance Ethics Healthcare Healthcare 249

European Pharmaceutical Review

OCTOBER 16, 2023

The new filling line is projected to be operational in 2027. Approximately 115 new jobs are expected to be created. Enhancing manufacturing capabilities The bioconjugates market is currently valued at $33 billion according to research by Lonza.

Manufacturing 100

Manufacturing Marketing Networking Pharmaceutical 100

European Pharmaceutical Review

NOVEMBER 20, 2023

While the new site is anticipated to be operational at the start of 2027, the investment in Alzey is contingent upon finalisation of government permitting and local approvals, Eli Lilly stated. To support reliable medicine supply, since 2020, Eli Lilly has announced investments of over $11 billion in its global manufacturing footprint.

Manufacturing 90

Manufacturing Medicine Biopharma Engineering 90

Penrod

APRIL 1, 2024

CMS has extended payers’ compliance dates to the new rule to January 2027, giving payers more time for implementation. Medicare FFS electronic prior authorization API provides evidence of advantages other payers would get on implementing a similar API.

Electronics 52

Electronics Insurance Healthcare Healthcare 52

European Pharmaceutical Review

OCTOBER 18, 2022

Global pharma contract manufacturing market to value $120bn by 2027… The post HPAPI contract manufacturing to value $14.6 billion by 2030 appeared first on European Pharmaceutical Review.

Manufacturing 99

Manufacturing Pharma Pharmaceutical Marketing 99

Pharmaceutical Technology

MAY 19, 2023

AbbVie anticipates Rinvoq sales to exceed $7.5bn in 2025 and for the peak revenues from both drugs to exceed Humira’s peak sales by 2027.

Food and Drug Administration 105

Food and Drug Administration FDA Sales Food 105

European Pharmaceutical Review

DECEMBER 2, 2022

The facility is planned for completion in 2027. The investment will support the addition of new technologies to ensure Pfizer is ready to facilitate the next generation of medical innovations, and to help increase capacity for licensed and pipeline products in oncology, rare disease, inflammation & immunology and internal medicines.

Manufacturing 99

Manufacturing Medicine Networking Medical 99

European Pharmaceutical Review

SEPTEMBER 21, 2023

The Novo Nordisk Foundation Cellerator is expected to be in operation in 2027. “We believe the Novo Nordisk Foundation Cellerator can be a leading player in Europe and a model for similar facilities around the world,” Professor Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation commented.

Manufacturing 112

Manufacturing Leads Networking Pharmaceutical 112

European Pharmaceutical Review

FEBRUARY 8, 2023

Breyanzi sales will also be supplemented by the anticipated approval in chronic lymphocytic leukemia (CLL) in 2027, making it the first and only currently marketed CD19 CAR-T agent to penetrate the CLL market. Breyanzi will exhibit the largest compound annual growth rate (CAGR) at 30 percent, compared to Yescarta’s CAGR of 9 percent.

Marketing 97

Marketing Sales Physicians Patients 97

Contrarian Sales Techniques

FEBRUARY 1, 2023

billion by 2027, growing at a CAGR of 7.7% from 2020 to 2027. Another factor contributing to the growth in milk product sales is the increasing popularity of alternative milk options, such as almond, soy, and oat milk. The alternative milk market is projected to reach $24.9

Sales Strategy 52

Sales Strategy Sales Sales pitches Prospecting 52

European Pharmaceutical Review

MAY 4, 2023

According to Research and Markets 8 , the market for bispecific antibodies for cancer is forecasted to grow by $400 million during 2022-2027, due to the increasing prevalence of cancer worldwide. Global Bispecific Antibodies for Cancer Market 2023-2027. Personalized medicine at FDA. Internet] Personalized Medicine Coalition.

Food and Drug Administration 96

Food and Drug Administration Safety Medicine Patients 96

European Pharmaceutical Review

JULY 18, 2022

Nebido is also patented until March 2024 in the European Union and until May 2027 in the United States. The long-acting injectable treatment for testosterone deficiency has been commercially approved in more than 80 countries.

Medicine 88

Medicine Physicians Competition Patients 88

European Pharmaceutical Review

JUNE 15, 2023

Rapid microbiology testing market growth expected 2022 to 2027 The post Why is microbiological testing in medical device manufacturing important? Therefore, with “careful consideration and planning, manufacturers can develop reliable and accurate microbiology testing methods that ensure the safety and efficacy of their medical devices.”

Manufacturing 86

Manufacturing Medical Safety Transportation 86

Pharmaceutical Technology

FEBRUARY 21, 2023

In the long term, Comirnaty is expected to continue its momentum, with forecast sales up by more than 20% from 2024 to 2027. This is attributed to Q3 2022 approvals for Comirnaty’s BA.4 This is likely due to Pfizer’s announcement to increase Comirnaty’s US prices four-fold this year from an average of $30/dose to an estimated $110–130/dose.

Sales 98

Sales Government Leads Medicine 98

pharmaphorum

JANUARY 17, 2023

It reckons the market opportunity for Winterlight’s technology could be worth around $30 million in 2027, and expects it to contribute around £2 million ($2.5 The company cites market research which predicts that the voice biomarkers market is growing at 66% a year and could reach around $220 million by 2026.

Healthcare 98

Healthcare Healthcare Marketing Patients 98

Pharmaceutical Technology

SEPTEMBER 23, 2022

It will expire on 24 November 2026, and the paediatric exclusivity lasts until 24 May 2027. The suit involved two Merck patents. The first is for the dihydrogen phosphate salt of sitagliptin. Merck’s second patent covers the co-formulation of sitagliptin and metformin present in Janumet.

Food and Drug Administration 69

Food and Drug Administration FDA Food Marketing 69

European Pharmaceutical Review

SEPTEMBER 7, 2023

Researchers can apply for grants and bid to take part in projects with certainty that the UK will be participating as a fully associated member until the deal reaches its end in 2027.

Government 84

Government Competition Pharmaceutical Manufacturing 84

European Pharmaceutical Review

SEPTEMBER 28, 2023

EMA prepares for winter antibiotic shortages PFAS restriction in pharmaceutical manufacturing In its current form, the procedure currently underway could lead to a ban on all PFASs by 2027, with very limited derogations, EFPIA acknowledged.

Pharmaceutical manufacturing 101

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 101

European Pharmaceutical Review

JANUARY 19, 2023

The additional support from Amgen is set to reach more than 300 diverse and community-oriented clinical investigators by 2027. The Winn Award Program has so far trained 114 early-stage investigator physicians.

Food and Drug Administration 88

Food and Drug Administration Physicians Medicine Food 88

pharmaphorum

JULY 15, 2022

The company – which announced plans to go public earlier this year – is addressing a growth market valued at around $25 billion in 2020 and estimated to grow at around 15% a year to reach $65 billion in 2027, according to market research company GMI. The post Akili digital therapeutic shows promise in lupus patients appeared first on.

Patients 104

Patients Engineering Marketing Medical 104

Medico Reach

DECEMBER 2, 2022

billion , and by 2027, it is expected to reach around an exciting amount of 115.1 from 2022 to 2027. A CRO offers comprehensive support to their efforts to test, examine, refine and market the latest medicines and devices that help in improving Healthcare Industry. In 2022, the global clinical research market stands at $63.6

Consulting 98

Consulting Specialization Medicine Medical 98

pharmaphorum

OCTOBER 17, 2022

9,187,405, granted in 2015, which comes to an end in 2027. It has been fighting a rear-guard action to try to protect the drug, with legal judgments going both ways over the last few months as Novartis tried to prevent generics reaching the US market until the expiration of its US patent No.

Competition 52

Competition Marketing Pharma Sales 52

pharmaphorum

JANUARY 9, 2023

FDA approval in this indication would unlock the additional $10 CVR payment, providing it takes place before the end of 2027. BA is the leading cause of liver transplant in children and is caused by damaged or absent bile ducts, leading to build-up of bile in the liver and cirrhosis.

Transportation 52

Transportation Sales Leads FDA 52

Pharmaceutical Technology

DECEMBER 16, 2022

This therapy is currently in Phase II development and is expected to launch in the US and 5EU in 2027 and 2028, respectively. GlobalData’s report also covers a third pipeline candidate, quinagolide, a dopamine receptor antagonist being developed by Ferring Pharmaceuticals.

Marketing 59

Marketing Side effects Sales Safety 59

Medico Reach

SEPTEMBER 12, 2022

With an increase in market share, North America displays the most significant gastrointestinal endoscopic devices market growth , with trends indicating an annual growth rate of 6.95% from 2022 to 2027, expected to reach a value of 21.16 billion by 2027. The current valuation is 15.12 Final Thoughts.

Marketing 52

Marketing Doctors Training Medical 52

pharmaphorum

JULY 18, 2022

It had expected the drug would not face biosimilar competition in Europe until at least 2027. Last year, Polpharma and Sandoz won a patent challenge in Europe that resulted in revocation of a key patent on Tysabri in the EU, slashing Biogen’s protection for the brand by more than five years.

Competition 52

Competition Marketing Sales Medicine 52